Biomarkers of Impending Preeclampsia
Robert L. Barbieri
Abstract
Robert L. Barbieri
Abstract
Preeclampsia, diagnosed in about 5% of pregnancies, is defined as the presence of new-onset hypertension and proteinuria after 20 weeks' gestation. Placental vascular dysfunction has been shown to precede the onset of preeclampsia, causing an increase in placental secretion of an antiangiogenic factor (soluble fms-like tyrosine kinase 1; sFlt-1) and a decrease in secretion of an angiogenic factor (placental growth factor; PlGF). In an industry-supported study, investigators explored the clinical value of …
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Preeclampsia, diagnosed in about 5% of pregnancies, is defined as the presence of new-onset hypertension and proteinuria after 20 weeks' gestation. Placental vascular dysfunction has been shown to precede the onset of preeclampsia, causing an increase in placental secretion of an antiangiogenic factor (soluble fms-like tyrosine kinase 1; sFlt-1) and a decrease in secretion of an angiogenic factor (placental growth factor; PlGF). In an industry-supported study, investigators explored the clinical value of …
Key concepts: Placental growth factor, Preeclampsia, Medicine, Proteinuria, Soluble fms-like tyrosine kinase-1, Gestation, Secretion, Placenta